Indefinitely prolonged survival after relapse in advanced ovarian cancer: The other end of the telescope

Gynecologic Oncology

Volumn 115, Issue 2, 2009, Pages 317-318

  Kapnick, Jason ^a   Helgason, Helga ^b  

^a DUKE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYTOREDUCTIVE SURGERY; ECONOMIC EVALUATION; FALCIFORM LIGAMENT; HUMAN; INCISION; LETTER; LIVER HILUS; MESENTERY; METASTASIS; MORBIDITY; OVARY CANCER; OVARY CARCINOMA; PERITONEUM; PRIORITY JOURNAL; TREATMENT OUTCOME; VISCERA;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 70349746946     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.024     Document Type: Letter

References (12)

1. Bristow R.E., Puri A., and Chi D.S. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol. Oncol. 112 (2009) 265-274
2. Griffiths C.T., and Fuller J.R.A.F. Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg. Clin. North Amer. 58 1 (1978) 131-142
3. Bristow R.E., Santillan A., Diaz-Montes T.P., Gardner G.J., Giuntoli R.L., and Meisner P.C. Centralization of care for patients with advanced - stage ovarian cancer: a cost-effectiveness analysis. Cancer 109 8 (2007) 1513-1522
4. Aletti G.D., Podratz K.C., Moriarty J.D., Cliby W.A., and Long K.H. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis. Gynecol. Oncol. 112 (2009) 16-21
5. Case A.S., Rocconi R.D., Partridge E.E., and Spraughn J.R.J.M. A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer. Gynecol. Oncol. 105 (2007) 223-227
6. Finkler N.J., Kapnick S.J., and Griffiths C.T. Serum OC. 125 antigen testing identifies isolated recurrence of ovarian adenocarcinoma in renal retroperitoneal lymph nodes. Gynecol. Oncol. 29 (1988) 356-358
7. Kapnick S.J. Secondary cytoreductive surgery in ovarian cancer produces increase in survival in selected subgroups of patients. Gynecol Oncol 48 (1993) 273
8. Kapnick S.J. Colon surgery in ovarian cancer patients: role of frank resection. Gynecol. Oncol. 46 (1992) 138
9. Kapnick S.J., Griffiths C.T., and Finkler N.J. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol. Oncol. 39 (1990) 135-138
10. Wimberger P., Lemann N., Kimming R., Burges A., Meier W., and Dubois A. Diagnostic factors for complet debulking in advanced ovarian cancer and its impact and survival. Gynecol. Oncol. 106 (2007) 69-74
11. Bristow R.E. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen. Gynecol. Oncol. 112 (2009) 1-3
12. Helm C.W., Randall-Whitis L., Martin R.S., Metzinger D.S., Gardinier M.E., Parker L.P., et al. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol. Oncol. 105 (2007) 90-96